593 related articles for article (PubMed ID: 16125778)
1. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
Panhotra BR; Bahrani A; Joshi CS; ul Hassan Z
J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
[No Abstract] [Full Text] [Related]
2. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
3. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
Kleinman SH; Strong DM; Tegtmeier GG; Holland PV; Gorlin JB; Cousins C; Chiacchierini RP; Pietrelli LA
Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
[TBL] [Abstract][Full Text] [Related]
5. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
6. Donor screening for hepatitis B virus infection in a cell and tissue bank.
Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
[TBL] [Abstract][Full Text] [Related]
7. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
8. Nucleic acid testing to detect HBV infection in blood donors.
Stramer SL; Wend U; Candotti D; Foster GA; Hollinger FB; Dodd RY; Allain JP; Gerlich W
N Engl J Med; 2011 Jan; 364(3):236-47. PubMed ID: 21247314
[TBL] [Abstract][Full Text] [Related]
9. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
Bouchardeau F; Girault A; Razer A; Servant-Delmas A; Mercier M; Laperche S
Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
[TBL] [Abstract][Full Text] [Related]
11. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
12. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
14. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
[TBL] [Abstract][Full Text] [Related]
15. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg].
Ren F; Li H; Zhao H
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742
[TBL] [Abstract][Full Text] [Related]
16. Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks.
Bamaga MS; Azahar EI; Al-Ghamdi AK; Alenzi FQ; Farahat FM
Saudi Med J; 2009 Nov; 30(11):1416-21. PubMed ID: 19882053
[TBL] [Abstract][Full Text] [Related]
17. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
[TBL] [Abstract][Full Text] [Related]
18. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
19. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg.
Antar W; El-Shokry MH; Abd El Hamid WA; Helmy MF
Transfus Med; 2010 Dec; 20(6):409-13. PubMed ID: 20573069
[TBL] [Abstract][Full Text] [Related]
20. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
